Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 oct. 2018 08h00 HE | Source: Cofactor Genomics

Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories

--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions-- SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cofactor...
02 oct. 2018 08h00 HE | Source: Cofactor Genomics

Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM

CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
20 mars 2018 08h30 HE | Source: Cofactor Genomics

Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay

SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...
08 févr. 2018 08h00 HE | Source: Cofactor Genomics

Cofactor Genomics Launches Paragon, a Comprehensive Quantitative Solid Tumor Immune Profiling Assay

SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor...